General Probiotics, Inc.

Fighting bacterial infections. Securing safe food production.

  • Stage Product In Development
  • Industry Biotechnology
  • Location St Paul, MN, USA
  • Currency USD
  • Founded August 2014
  • Employees 4
  • Incorporation Type C-corp
  • Website gprobiotics.com

Company Summary

At General Probiotics we develop a new class of antimicrobials: probiotic bacteria that express and secrete antimicrobial peptides to eliminate antibiotic-resistant bacteria.

We leverage a new generation of synthetic biology techniques to develop novel therapeutics and prophylactics for antibiotic-resistant E. coli, Salmonella, Enterococcus, Staphylococcus, Listeria, Clostridia and Campylobacter.

Team

  • Yiannis Kaznessis
    Chief Executive Officer

    Dr. Kaznessis founded GP and joined as CEO in 2017. He received a diploma in chemical engineering at the Aristotle University in 1994, and a Ph.D. in chemical engineering at the University of Notre Dame in 1999. He completed postdoctoral research at Pfizer Global R&D.

    Dr. Kaznessis is a world expert in antimicrobial technologies. He has authored more than 110 refereed papers and the textbook “Statistical Thermodynamics and Stochastic Kinetics.”

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free